Joint European Disruptive Initiative

The Joint  European Disruptive Initiative (JEDI) is a European funding agency aiming at promoting disruptive technologies. Inspired by the US DARPA,[1] it funds innovation in different "missions" (environment and energy, healthcare, education, digital, space, and oceans),[2] with the goal of bringing "Europe in a leadership position in breakthrough technologies".[3] It organizes scientific competitions focused on disruptive technologies.[4] In June 2020, the Joint European Disruptive Initiative was present in 25 countries, with 3.700 persons involved.[5]

Joint European Disruptive Initiative
TypeFunding agency
HeadquartersParis, France
Location
President
André Loesekrug-Pietri
Vice-President
Antoine Petit
Websitehttps://www.jedi.foundation

Research on Covid-19

The Joint European Disruptive Initiative launched its first "Darpa-type GrandChallenge"[6] on Covid-19 on May 5, 2020.[7] The competition consisted in screening "billions of molecules with blocking interactions on SARS-CoV-2" to develop a drug against the coronavirus — with each participant having to use at least three different calculation methods for the simulations.[8] The foundation claims to have had approximately 54 billions of molecules screened [9] and 878 of them being synthesized. A paper published in Nature showed that the protein PDB 6W9C was one of the most used in silico drug design against Covid-19.[10]

References
  1. Europe and AI: Leading, Lagging Behind, or Carving Its Own Way?
  2. Loesekrug-Pietri, Andre. "Breaking the Wall to European Tech Sovereignty | Falling Walls". Falling Walls. Retrieved 2021-11-11.
  3. "The Next Generation of Climate Innovation". BCG Global. 2021-03-11. Retrieved 2021-11-11.
  4. JEDI – a force to be reckoned with
  5. Maward, Marie (5 June 2020). "Meet JEDI: Europe's equivalent to DARPA? | Sifted". sifted. Retrieved 2021-11-11.
  6. "20 Years After 9/11: Achievements and Challenges of EU Counter-Terrorism Efforts" (PDF). Council of the European Union. 8 July 2021.
  7. McKee, Selina (2020-05-05). "JEDI launches billion molecules against COVID19 challenge". PharmaTimes. Retrieved 2021-11-11.
  8. "Austrians as finalists in the biggest programme searching for drugs against COVID-19". investinaustria.at. Retrieved 2021-11-11.
  9. "Billion Molecules". JEDI Foundation. Retrieved 2021-11-11.
  10. Croll, Tristan I.; Diederichs, Kay; Fischer, Florens; Fyfe, Cameron D.; Gao, Yunyun; Horrell, Sam; Joseph, Agnel Praveen; Kandler, Luise; Kippes, Oliver; Kirsten, Ferdinand; Müller, Konstantin (10 May 2021). "Making the invisible enemy visible". Nature Structural & Molecular Biology. 28 (5): 404–408. doi:10.1038/s41594-021-00593-7. ISSN 1545-9985. PMC 8340564. PMID 33972785.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.